Asieris(SH:688176) Zhong Guo Jing Ji Wang·2025-08-20 08:04Core Viewpoint - Yahui Pharmaceutical (688176.SH) is currently trading at 12.07 yuan, reflecting a decline of 1.55%, and is in a state of share price decline since its IPO [1] Group 1: IPO Details - Yahui Pharmaceutical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 7, 2022, with an issuance of 110 million shares at a price of 22.98 yuan per share [1] - The stock opened below the issue price on its first trading day, reaching a maximum price of 20.00 yuan, which remains the highest price since its listing [1] - The total funds raised from the IPO amounted to 2.528 billion yuan, with a net amount of 2.381 billion yuan after deducting issuance costs, exceeding the original plan by 311 million yuan [1] Group 2: Fund Utilization - The funds raised are intended for various projects, including drug and medical device production, new drug research and development, marketing network construction, and working capital supplementation [1] Group 3: Underwriting and Fees - The total cost of the IPO was 147 million yuan, with CITIC Securities receiving 130 million yuan as underwriting and sponsorship fees [1] Group 4: Company Leadership - The controlling shareholder and actual controller of Yahui Pharmaceutical is PAN KE, who holds American nationality and serves as the chairman and general manager [1]